Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70

BACKGROUND: Radiofrequency ablation (RFA) is widely used in palliative therapy of malignant cancers. Several studies have shown its applicability and safety for locally advanced pancreatic cancer (LAPC). The objective of this study was to modify the current regimen to improve its therapeutic effect....

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shanshan, Pu, Ning, Yin, Hanlin, Li, Junhao, Chen, Qiangda, Yang, Minjie, Lou, Wenhui, Chen, Yi, Zhou, Guofeng, Li, Changyu, Li, Guoping, Yan, Zhiping, Liu, Lingxiao, Yu, Jun, Wang, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491221/
https://www.ncbi.nlm.nih.gov/pubmed/32973929
http://dx.doi.org/10.1177/1758835920953728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491221/
https://www.ncbi.nlm.nih.gov/pubmed/32973929
http://dx.doi.org/10.1177/1758835920953728

Ejemplares similares